Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms

• Published in: Leukemia Vol. 35; no. 12; pp. 3573 - 3577
• Main Authors: Harrington, Patrick, de Lavallade, Hugues, Doores, Katie J., O’Reilly, Amy, Seow, Jeffrey, Graham, Carl, Lechmere, Thomas, Radia, Deepti, Dillon, Richard, Shanmugharaj, Yogita, Espehana, Andreas, Woodley, Claire, Saunders, Jamie, Curto-Garcia, Natalia, O’Sullivan, Jennifer, Raj, Kavita, Kordasti, Shahram, Malim, Michael H., Harrison, Claire N., McLornan, Donal P.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.12.2021; Nature Publishing Group
• Subjects: 13/21; 13/31; 631/250/255; 692/308/575; 692/699/1541/1990/2331; 82/1; Antibodies; Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; Cancer Research; Care and treatment; Coronaviruses; COVID-19 - complications; COVID-19 - prevention & control; COVID-19 Vaccines - administration & dosage; COVID-19 Vaccines - immunology; Critical Care Medicine; Drug dosages; Health aspects; Hematology; Humans; Immunization; Infections; Intensive; Internal Medicine; Letter; Lymphocytes T; Medicine; Medicine & Public Health; Messenger RNA; mRNA; mRNA Vaccines; Myeloproliferative disorders; Myeloproliferative Disorders - immunology; Neoplasms; Oncology; Patients; SARS-CoV-2 - immunology; Severe acute respiratory syndrome coronavirus 2; T cells; T-Lymphocytes - immunology; Tumors; Vaccines; Vaccines, Synthetic - administration & dosage; Vaccines, Synthetic - immunology; Viral infections; United Kingdom
• ISSN: 0887-6924; 1476-5551
• DOI: 10.1038/s41375-021-01300-7